The use of hypnotic and sedative medicine in the UK showcased a mixed trend from 2013 through 2023. Starting with 11.1 units in 2013, the value saw diminishing returns each subsequent year until 2017. However, 2018 marked a resurgence with an increase to 11.1 units, maintaining relatively stable usage thereafter with minor fluctuations. By 2023, the figure stood steady at 11.3 units. The CAGR over the last five years up to 2023 was minimal at 0.36%, indicating a stable yet slightly increasing trend.
Looking ahead, forecasted data from 2024 to 2028 suggests a plateau in the use of hypnotic and sedative medicine, consistently at 11.3 units per day per thousand persons. The forecasted CAGR over the next five years is expected to remain at 0%, indicating no significant growth or decline. Future trends to watch for include potential impacts of new medical guidelines, alternative therapies, and changes in public health initiatives focusing on mental health and sleep disorders.
